Description
LIPOSOMAL DELIVERY INGREDIENT
Liposomal NAD (beta-Nicotinamide adenine dinucleotide) Powder
Liposomal NAD (beta-Nicotinamide adenine dinucleotide) is supplied as a phospholipid-encapsulated powder for formulators who need the active dispersed in a lipid bilayer rather than as a free crystalline solid. This grade is offered as a B2B raw material: 50% NAD of the active on a phospholipid carrier, produced by thin-film hydration followed by high-pressure homogenisation and spray drying. It is intended for further processing by the buyer (capsules, stick packs, sachets, liquid or powder blends). The material is characterised by phospholipid identity, particle-size distribution and encapsulation-related parameters rather than by crystallinity, so the specification below is written accordingly.
COA-Backed Specification
| Ingredient system | Liposomal NAD (beta-Nicotinamide adenine dinucleotide) (phospholipid bilayer encapsulation) |
|---|---|
| Form and colour | Fine off-white powder |
| Assay | 50.0% |
| Method | HPLC |
| Particle size | 98% through 80 mesh |
| Loss on drying | <=5.0%; result 3.80% |
| Ash | <=5.0%; result 2.60% |
| Heavy metals | Within the limits of the approved specification |
| Microbiological limits | Within the limits of the approved specification |
| Representative batch | LXLP260505 |
| Manufacture date | 5 May 2026 |
| Shelf life | Two years when stored properly |
Representative values do not replace the current shipment COA.
Buyer Decision Guide
Liposomal grades are specified differently from plain powders. Buyers should agree on three things before approval: the carrier system (phosphatidylcholine from sunflower or soy lecithin, or a synthetic phospholipid), the declared active content of the encapsulated system, and the dispersion behaviour in the buyer’s own matrix. Confirm the intended final dosage form at enquiry stage.
- Active content: 50% NAD on a phospholipid carrier, expressed on the encapsulated system rather than on total powder mass.
- Carrier declaration: phosphatidylcholine source and phospholipid content are stated on the COA for identity control.
- Particle size: micro-dispersible powder, specification agreed against the dispersion test the buyer will run.
- Dispersion: designed to disperse in water and in oil-free aqueous matrices; evaluate in your own base before scale-up.
- Handling: hygroscopic, sensitive to heat and oxygen; keep sealed, cool and dry, and open only under controlled conditions.
- This material is a raw material for further processing, not a finished consumer product.
How This Grade Differs
Liposomal NAD (beta-Nicotinamide adenine dinucleotide) is not interchangeable with plain NAD (beta-Nicotinamide adenine dinucleotide) powder on a weight-for-weight basis. The active is held in a phospholipid bilayer, so the declared content refers to the encapsulated system, and the material behaves differently in dispersion, taste masking and flow. Buyers comparing quotations should normalise on the active content stated on the COA, not on the price per kilogram of powder.
Compare these related grades before approval:
For a substitution review, compare botanical identity, plant part, assay target, analytical method, physical form and the current offered-batch COA.
Application Areas
- Hard capsules and two-piece capsule filling
- Stick packs and single-serve sachets
- Powder blends and dry mixes
- Beverage and liquid concentrate systems, subject to the buyer’s process validation
Packaging and Delivery
- Evaluation sample typically 10-20 g, subject to stock
- Regular MOQ typically 1 kg
- 1 kg foil bag or 25 kg fibre drum with inner food-grade liner
- Custom packing and private-label options subject to confirmation
- Typical lead time 7-15 working days after deposit
Quality and Documentation
Representative batch LXLP260505 supports the specification table above. Use the cited record for preliminary comparison and request the offered-lot COA for final technical approval. Batch COA, specification sheet, agreed third-party testing and export documents are available for buyer verification.
Frequently Asked Questions
What specification defines Liposomal NAD Powder 50%?
For Liposomal NAD Powder 50%: 50.0%, tested by HPLC.
Which identity details must remain consistent?
For Liposomal NAD Powder 50%: match Liposomal NAD (beta-Nicotinamide adenine dinucleotide) (phospholipid bilayer encapsulation) across the quotation, specification and offered-batch COA. The offered grade is 50.0%.
How is batch-specific approval completed?
For Liposomal NAD Powder 50%: the page cites representative batch LXLP260505. Final approval requires the current lot’s identity, specification results and relevant dates.
What forms part of the technical review?
For Liposomal NAD Powder 50%: do not assess 50.0% in isolation; particle size, moisture or drying data and market-relevant safety limits can also affect acceptance.
Are you a manufacturer or a trading company?
LongBio is Shaanxi Longsheng Biotechnology Co., Ltd., a direct manufacturer of botanical extracts and functional ingredients integrating R&D, production and export support. Factory review can be arranged by video or an on-site visit.
Can I request the current batch COA before ordering?
Yes. Request the applicable current or representative COA and compare product identity, method, limits and results before approving a purchase order.
What is the minimum order quantity?
The regular MOQ is typically 1 kg. An evaluation sample of 10-20 g can usually be arranged before a formal order, subject to stock.
Do you support custom specifications or packing?
Alternative assay targets, particle size, packing and private-label requirements can be reviewed case by case, subject to production feasibility and a revised written specification.
Request COA, Sample or Quotation
Send your target specification, application, order quantity, destination country and required test limits.
Reviews
There are no reviews yet.